Regeneron Pharmaceuticals
Pharmaceutical & Health Products · Lobbying Client
B
Influence Score
62/100
High Influence
$10.2M
Total Lobby Spend
4
Policy Issues
4
Lobbyists
2
Revolving Door
Regeneron Pharmaceuticals reported $10.2 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Health & Human Services
Dept of Agriculture
Small Business Administration
Federal Communications Commission
Federal Energy Regulatory Commission
Dept of Commerce
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Cassidy & Associates LLP | PHAGOVHCR+1 | 4 | $300K |
| 2020 Apr-Jun | Squire Patton Boggs LLP | GOVHCR | 4 | $442K |
| 2020 Jul-Sep | K&L Gates LLP | GOVMEDHCR | 1 | $453K |
| 2020 Oct-Dec | Cassidy & Associates LLP | PHAGOVHCR | 3 | $451K |
| 2021 Jan-Mar | Cassidy & Associates LLP | GOVPHA | 2 | $694K |
| 2021 Apr-Jun | Brownstein Hyatt LLP | PHAGOVHCR | 4 | $441K |
| 2021 Jul-Sep | K&L Gates LLP | PHAGOV | 1 | $624K |
| 2021 Oct-Dec | BGR Group LLP | MEDPHAHCR+1 | 1 | $649K |